192 related articles for article (PubMed ID: 32294817)
1. [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019].
Liu YJ; Yang YL; Xu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):339-344. PubMed ID: 32294817
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV.
Singh A; Singh RS; Sarma P; Batra G; Joshi R; Kaur H; Sharma AR; Prakash A; Medhi B
Virol Sin; 2020 Jun; 35(3):290-304. PubMed ID: 32607866
[TBL] [Abstract][Full Text] [Related]
3. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
Front Immunol; 2020; 11():1022. PubMed ID: 32574260
[TBL] [Abstract][Full Text] [Related]
4. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
Front Immunol; 2020; 11():1979. PubMed ID: 32973803
[TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent enhancement and COVID-19: Moving toward acquittal.
Yager EJ
Clin Immunol; 2020 Aug; 217():108496. PubMed ID: 32526272
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine therapy during the COVID-19 pandemic.
Rudnicka L; Glowacka P; Goldust M; Sikora M; Sar-Pomian M; Rakowska A; Samochocki Z; Olszewska M
J Am Acad Dermatol; 2020 Aug; 83(2):e151-e152. PubMed ID: 32376422
[No Abstract] [Full Text] [Related]
7. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
Lin L; Lu L; Cao W; Li T
Emerg Microbes Infect; 2020 Dec; 9(1):727-732. PubMed ID: 32196410
[TBL] [Abstract][Full Text] [Related]
8. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV.
Lee PI; Hsueh PR
J Microbiol Immunol Infect; 2020 Jun; 53(3):365-367. PubMed ID: 32035811
[No Abstract] [Full Text] [Related]
9. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
Yao Z; Zheng Z; Wu K; Junhua Z
Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
[TBL] [Abstract][Full Text] [Related]
10. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.
Astuti I; Ysrafil
Diabetes Metab Syndr; 2020; 14(4):407-412. PubMed ID: 32335367
[TBL] [Abstract][Full Text] [Related]
11. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
Ye ZW; Jin DY
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
[TBL] [Abstract][Full Text] [Related]
13. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
[TBL] [Abstract][Full Text] [Related]
14. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.
Jamwal S; Gautam A; Elsworth J; Kumar M; Chawla R; Kumar P
Life Sci; 2020 Sep; 257():118105. PubMed ID: 32687917
[TBL] [Abstract][Full Text] [Related]
15. Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
Rokni M; Ghasemi V; Tavakoli Z
Rev Med Virol; 2020 May; 30(3):e2107. PubMed ID: 32267987
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
[TBL] [Abstract][Full Text] [Related]
17. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
Liu J; Zheng X; Tong Q; Li W; Wang B; Sutter K; Trilling M; Lu M; Dittmer U; Yang D
J Med Virol; 2020 May; 92(5):491-494. PubMed ID: 32056249
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
Bergmann CC; Silverman RH
Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
[No Abstract] [Full Text] [Related]
19. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
Asrani P; Hasan GM; Sohal SS; Hassan MI
OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
[TBL] [Abstract][Full Text] [Related]
20. Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques.
Song TZ; Zheng HY; Han JB; Jin L; Yang X; Liu FL; Luo RH; Tian RR; Cai HR; Feng XL; Liu C; Li MH; Zheng YT
Zool Res; 2020 Sep; 41(5):503-516. PubMed ID: 32772513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
